ERBB3 and ABL2

  • Number of citations of the paper that reports this interaction (PMID 16273093)
  • 170
  • Data Source:
  • BioGRID (unspecified method)

ERBB3

ABL2

Gene Name erb-b2 receptor tyrosine kinase 3 ABL proto-oncogene 2, non-receptor tyrosine kinase
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 66 interactors: ABL1 ABL2 AGTR2 BCAR3 CD82 CDK5 CHN2 CRK CRKL DAB1 DAPP1 EGF EGFR EGR1 ERBB2 ERBB4 FER FGFR1 FLNA FLYWCH1 GRB2 GRB7 HCK HDAC6 IL6ST ITK JAK2 JAK3 MUC1 NCK1 NCK2 NEDD4 NRG1 NRG2 ODF2L PA2G4 PIK3R1 PIK3R2 PIK3R3 PLCG1 PTGES3 PTK2 PTK2B PTK6 RASA1 RASA4 RGS4 RIN1 RNF41 RPN1 SH2B3 SH2D1A SHC1 SHC3 SOS1 SRC SYK TNS2 TNS3 TNS4 TXK VAV1 VAV2 VAV3 ZAP70 ZNF207 25 interactors: ABL1 BCR C15orf48 CAT CRK DOK1 EGFR EPHB2 ERBB2 ERBB3 ERBB4 FBXO38 GPX1 GRB2 HCK MAP3K10 NEDD4 NEDD4L OIP5 PSMA7 RIN1 SIVA1 SORBS2 TPD52L1 TRIP10
Entrez ID 2065 27
HPRD ID 01820 01259
Ensembl ID ENSG00000065361 ENSG00000143322
Uniprot IDs P21860 P42684
PDB IDs 1M6B 2L9U 3KEX 3LMG 3P11 4LEO 2ECD 2KK1 2XYN 3GVU 3HMI 3ULR 4EIH
Enriched GO Terms of Interacting Partners?
Tagcloud ?
acquire  alteration  associate  cascades  concurrent  dependence  egf  enhancing  latent  mapk  mediators  p42  p44  phosphotyrosine  potentiates  potentiating  predicts  prime  priming  progestin  progestins  r5020  shc  shift  stat5  steroid  switches  synergistically  waf1 
abl1  adding  amenable  charities  crizotinib  crlf2  csf1r  dasatinib  epor  etv6  flt3  funded  fusions  il7r  lebanese  lymphoblastic  ntrk3  pdgfrb  ph  philadelphia  ptk2b  rearrangements  responsiveness  ruxolitinib  sh2b3  syrian  tslp  tyk2  undefined 
Tagcloud (Difference) ?
acquire  alteration  associate  cascades  concurrent  dependence  egf  enhancing  latent  mapk  mediators  p42  p44  phosphotyrosine  potentiates  potentiating  predicts  prime  priming  progestin  progestins  r5020  shc  shift  stat5  steroid  switches  synergistically  waf1 
abl1  adding  amenable  charities  crizotinib  crlf2  csf1r  dasatinib  epor  etv6  flt3  funded  fusions  il7r  lebanese  lymphoblastic  ntrk3  pdgfrb  ph  philadelphia  ptk2b  rearrangements  responsiveness  ruxolitinib  sh2b3  syrian  tslp  tyk2  undefined 
Tagcloud (Intersection) ?